[ad_1]
KUALA LUMPUR (December 15): Widad Group Bhd is collaborating with Rinani Dynamic Sdn Bhd in the distribution, marketing and sale of the Covid-19 vaccine known as Vxa-Cov2-1 and other products developed by EE-based Vaxart Inc In Malaysia.
In a presentation to Bursa Malaysia, Widad said it had signed a memorandum of collaboration (MoC) with Rinani, which is involved in the investment advisory services business and other management consulting activities.
Widad said that on November 29, Hong Kong-based Majoritas Global Ltd appointed Rinani as its exclusive partner in Malaysia to present, discuss and negotiate with the relevant authorities and parties regarding the terms and conditions of testing, evaluation , marketing and contracting. , financing and purchasing the vaccine and other products in Malaysia.
“Although Widad may not have the prior experience to carry out the vaccine distribution, Widad will hire key personnel with additional experience to mitigate risks in due course,” he said.
Widad said that the MoC will be effective for a period of one year from the execution by both parties hereto and can be mutually extended by both parties.
[ad_2]
